DIM
TAK icon

DC Investments Management’s Takeda Pharmaceutical TAK Stock Holding History

DC Investments Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-17,041
Closed -$336K – 263
2019
Q4 		$336K Sell
17,041
-6,627
-28% -$127K 0.26% 182
2019
Q3 		$407K Hold
23,668
– – 0.24% 190
2019
Q2 		$419K Hold
23,668
– – 0.23% 186
2019
Q1 		$482K Buy
+23,668
New +$476K 0.31% 157

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DC Investments Management's TAK Position: Q1 2020 in Review

DC Investments Management sold out of Takeda Pharmaceutical (TAK) in Q1 2020, closing a stake of 17,041 shares — an estimated $336K sold.

DC Investments Management first reported a position in TAK in Q1 2019 and held it in 4 quarters. The position peaked at $482K in Q1 2019. 313 funds tracked by Wall St. Rank hold TAK as of Q1 2020.

  • DC Investments Management reported no remaining Takeda Pharmaceutical position as of Q1 2020 after selling out during the quarter.
  • DC Investments Management sold 17,041 Takeda Pharmaceutical shares in Q1 2020, an estimated $336K.
  • DC Investments Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 4 quarters.
  • DC Investments Management's Takeda Pharmaceutical position peaked at $482K in Q1 2019.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2020.

Based on DC Investments Management's 13F filing for Q1 2020, filed 11 May 2020.